Cargando…
Low-Dose Methotrexate and Serious Adverse Events Among Older Adults With Chronic Kidney Disease
IMPORTANCE: Low-dose methotrexate is used to treat rheumatoid arthritis and psoriasis. Due to its kidney elimination, better evidence is needed to inform its safety in adults with chronic kidney disease (CKD). OBJECTIVES: To compare the 90-day risk of serious adverse events among adults with CKD who...
Autores principales: | Muanda, Flory T., Blake, Peter G., Weir, Matthew A., Ahmadi, Fatemeh, McArthur, Eric, Sontrop, Jessica M., Urquhart, Brad L., Kim, Richard B., Garg, Amit X. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682837/ https://www.ncbi.nlm.nih.gov/pubmed/38010652 http://dx.doi.org/10.1001/jamanetworkopen.2023.45132 |
Ejemplares similares
-
Association of Higher-Dose Fluoroquinolone Therapy With Serious Adverse Events in Older Adults With Advanced Chronic Kidney Disease
por: Muanda, Flory Tsobo, et al.
Publicado: (2022) -
Adverse events with quetiapine and clarithromycin coprescription: A population‐based retrospective cohort study
por: Yau, Kevin, et al.
Publicado: (2023) -
Cardiovascular Safety of Metoclopramide Compared to Domperidone: A Population-Based Cohort Study
por: Cowan, Andrea, et al.
Publicado: (2020) -
Evaluation of Adverse Pregnancy Outcomes in Physicians Compared With Nonphysicians
por: Cusimano, Maria C., et al.
Publicado: (2022) -
Association of Current Opioid Use With Serious Adverse Events Among Older Adult Survivors of Breast Cancer
por: Winn, Aaron N., et al.
Publicado: (2020)